Poly(ionic liquid)/Ce-Based Antimicrobial Nanofibrous Membrane for Blocking Drug-Resistance Dissemination from MRSA-Infected Wounds

Resistant bacteria have become a global threat. Even if bacteria are killed, their carried drug-resistant genes can remain in the environment and spread to other microbes via horizontal gene transfer. Development of antimicrobial materials with intrinsic gene break down activity can prevent the dissemination of released drug-resistant genes from the dead bacteria. Herein, imidazolium type poly(ionic liquid) (PIL)/cerium (IV) ion-based electrospun nanofibrous membranes (PIL-Ce) are synthesized. The effects of PIL and Ce moieties on the antimicrobial properties against Gram-negative Escherichia coli and kanamycin-resistant E. coli, and Gram-positive Staphylococcus aureus and methicillin-resistant S. aureus (MRSA), as well as deoxyribonuclease-mimic activities to the drug-resistant genes of Kan(R) (E. coli) and mecA (MRSA) are investigated. The Ce-containing PIL membranes show the high efficiencies to eradicate bacteria and disintegrate drug-resistant genes. A wound treatment test using MRSA infected mice as the model further demonstrate that PIL-Ce membranes combine both antibacterial and DNase-mimic properties, and may have the potential application as a new green wound dressing to block the drug resistance spread in a clinical setting.

Automated summary

The antimicrobial PIL-Ce membranes showed high efficiencies in eradicating bacteria and disintegrating drug-resistant genes, with potential application as a new green wound dressing to block the spread of drug resistance in clinical settings.